IMR Press / CEOG / Volume 12 / Issue 3-4 / pii/1634257748985-926181430

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Evidence that adrenal oestrogens are not involved in benign breast disease
Show Less
1 Department of Obstetrics and Gynaecology and Department of Medicine, Hope Hospital - University of Manchester (England)
2 Department of Surgery, Withington Hospital - University of Manchester (England)
Clin. Exp. Obstet. Gynecol. 1985, 12(3-4), 47–51;
Published: 10 September 1985

We have studied 30 women with symptomatic benign breast disease in order to test the hypothesis that in some it might be caused by an enzyme variant leading to excessive adrenal production of oestrone. Synthetic 1-24 ACTH (Synacthen) was given intramuscularly after overnight suppression with dexamethasone, during the early follicular phase of the menstrual cycle. In no subjects did plasma oestrone levels show a consistent and significant response to ACTH despite the expected consistent rises in androstenedione and cortisol. We conclude that it is unlikely that adrenal oestrogens play a significant role in the pathophysiology of even a minority of patients with benign breast disease.
Back to top